These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31345068)

  • 21. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted nanoparticles for simultaneous delivery of chemotherapeutic and hyperthermia agents--an in vitro study.
    Srinivasan S; Manchanda R; Lei T; Nagesetti A; Fernandez-Fernandez A; McGoron AJ
    J Photochem Photobiol B; 2014 Jul; 136():81-90. PubMed ID: 24859437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
    Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells.
    Yoshida T; Kondo T; Ogawa R; Feril LB; Zhao QL; Watanabe A; Tsukada K
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):559-67. PubMed ID: 17505825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation.
    Gasselhuber A; Dreher MR; Negussie A; Wood BJ; Rattay F; Haemmerich D
    Int J Hyperthermia; 2010; 26(5):499-513. PubMed ID: 20377363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Doxorubicin Delivery Systems and Mild Hyperthermia on Tissue Penetration in 3D Cell Culture Models of Ovarian Cancer Residual Disease.
    Eetezadi S; De Souza R; Vythilingam M; Lessa Cataldi R; Allen C
    Mol Pharm; 2015 Nov; 12(11):3973-85. PubMed ID: 26394060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
    Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
    J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase.
    Guin S; Ma Q; Padhye S; Zhou YQ; Yao HP; Wang MH
    Cancer Chemother Pharmacol; 2011 May; 67(5):1073-83. PubMed ID: 20658288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse.
    Dorr RT; Alberts DS; Stone A
    Cancer Treat Rep; 1985 Apr; 69(4):431-7. PubMed ID: 3995512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperthermia sensitization and proton beam triggered liposomal drug release for targeted tumor therapy.
    Fernando R; Maples D; Senavirathna LK; Zheng Y; Polf JC; Benton ER; Bartels KE; Piao D; Ranjan A
    Pharm Res; 2014 Nov; 31(11):3120-6. PubMed ID: 24852892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulated electro-hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro.
    Vancsik T; Forika G; Balogh A; Kiss E; Krenacs T
    Cancer Med; 2019 Aug; 8(9):4292-4303. PubMed ID: 31183995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast Cancer Cell Lines MDA-MB-453 and MCF-7.
    Terasaki A; Kurokawa H; Ito H; Komatsu Y; Matano D; Terasaki M; Bando H; Hara H; Matsui H
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles.
    Augustin E; Czubek B; Nowicka AM; Kowalczyk A; Stojek Z; Mazerska Z
    Toxicol In Vitro; 2016 Jun; 33():45-53. PubMed ID: 26911730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of Protoporphyrin IX-mediated Sonodynamic Treatment with Doxorubicin Synergistically Induced Apoptotic Cell Death of a Multidrug-Resistant Leukemia K562/DOX Cell Line.
    Wang X; Jia Y; Su X; Wang P; Zhang K; Feng X; Liu Q
    Ultrasound Med Biol; 2015 Oct; 41(10):2731-9. PubMed ID: 26166458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
    Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
    Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
    Shen J; Zhang W; Wu J; Zhu Y
    Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes.
    Eliaz RE; Nir S; Marty C; Szoka FC
    Cancer Res; 2004 Jan; 64(2):711-8. PubMed ID: 14744789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
    Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
    Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.